What Cellectar Biosciences Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 0 | 1 |
| Total trades | 0 | 3 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 17,360 |
| Disposed | 0 | 198 |
| Net activity | +0 | +17,162 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Caruso James V | Chief Executive Officer | May 07 | Open-market buy · P | +8,680 | $2.88 | +$25K | 20,318 |
| Longcor Jarrod | Chief Operating Officer | May 07 | Open-market buy · P | +8,680 | $2.88 | +$25K | 20,451 |
| Neis John | Director | Dec 12 | Open-market sale · S | −198 | $3.70 | −$732 | 10 |
| Kolean Chad J | Chief Financial Officer | Jul 02 | Open-market buy · P | +5,000 | $4.99 | +$25K | 6,418 |
| Longcor Jarrod | Chief Operating Officer | Jul 02 | Open-market buy · P | +10,000 | $4.99 | +$49.9K | 12,768 |
| Caruso James V | Chief Executive Officer | Jul 02 | Open-market buy · P | +10,000 | $4.99 | +$49.9K | 11,638 |
| Longcor Jarrod | Chief Operating Officer | Jan 10 | Open-market buy · P | +30,000 | $0.28 | +$8.4K | 83,141 |
| Shustov Andrei | Senior Vice President, Medical | Dec 08 | Grant / award · A | +47,856 | — | — | 55,038 |
| Lea Darrell Shane | Chief Commercial Officer | Dec 08 | Grant / award · A | +39,599 | — | — | 39,599 |
| Caruso James V | President and CEO | Dec 08 | Grant / award · A | +40,596 | — | — | 49,236 |
| Longcor Jarrod | Chief Operating Officer | Dec 08 | Grant / award · A | +42,927 | — | — | 53,141 |
| Kolean Chad J | Chief Financial Officer | Dec 08 | Grant / award · A | +42,554 | — | — | 42,578 |
| Swirsky Douglas J | Director | Sep 14 | Open-market buy · P | +25,000 | $1.04 | +$26K | 25,000 |
| Driscoll Frederick W | Director | Sep 03 | Open-market buy · P | +19,417 | $1.04 | +$20.2K | 19,417 |
| Caruso James V | President and CEO | Mar 04 | Open-market buy · P | +5,100 | $1.70 | +$8.66K | 86,401 |
| Longcor Jarrod | Chief Business Officer | Dec 28 | Open-market buy · P | +29,630 | $1.35 | +$40K | 102,148 |
| Elefant Dov | Chief Financial Officer | Dec 28 | Open-market buy · P | +7,407 | $1.35 | +$10K | 11,755 |
| Caruso James V | President and CEO | Dec 28 | Open-market buy · P | +37,037 | $1.35 | +$50K | 81,301 |
| Caruso James V | President and CEO | Jun 05 | Open-market buy · P | +21,740 | $1.15 | +$24.9K | 44,264 |
| Longcor Jarrod | Chief Business Officer | Jun 05 | Open-market buy · P | +65,218 | $1.15 | +$74.7K | 72,518 |
Loading...